drugset / Trial / NCT00349037

Study of the Ability of a Flu Vaccine to Prevent Flu Infection

NCT00349037 ↗

Phase 1 Completed 105 enrolled PowderMed
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to evaluate how effective the vaccine is at preventing subjects developing flu symptoms after they are directly exposed to flu virus. The study will also evaluate how well the vaccine is tolerated at sites where administrations are given, any effects it may have on subjects' wellbeing and whether it can produce antibody responses in the body

Timeline

Start
2006-09
Primary completion
—
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Trivalent DNA vaccine Vaccine — —
Subject pPJV2012 Unknown — —

Indications